The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

Egypt - Macro Group Pharmaceutical (Macro Capital) suffered 86.02%% year-on-year (YoY) lower consolidated net losses attributable to the parent company at EGP 38.098 million in 2024, versus EGP ...

One Indian pharmaceutical company dey manufacture unlicensed, highly addictive opioids and dey export dem illegally to West Africa wia dem dey drive a major public health crisis for countries ...

A snapshot of the stocks on the move, featuring Domain Holdings Australia, Guzman y Gomez, Mayne Pharma, Rural Funds Group Domain Holdings Australia (ASX:DHG) has received an unsolicited, non-binding ...

A new executive committee has taken charge at the Pharmaceutical Research and Manufacturers Association Gulf for the period 2025–27. This diverse and accomplished group of industry leaders is ...

Kirby Group Engineering has announced a series of appointments at ... s ability to connect top talent with leading healthcare providers”. Chanelle Pharma announces the appointment of Jacob Kurdziel as ...

Dr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined by 3.2% to Rs 1,647.35, becoming the top loser on the BSE ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

(Image/Freepik) Donald Trump’s election victory was welcomed by many in India and especially by the Indian pharmaceutical industry. They saw in his return as the US president, elements that ...